ID
37753
Description
Study ID: 104864/517 Clinical Study ID: 104864/517 Study Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00158886 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Topotecan + Radiation therapy Trade Name: N/A Study Indication: Rectal Cancer, Carcinoma, Renal Cell
Mots-clés
Versions (1)
- 21/08/2019 21/08/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
21 août 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Oral Topotecan as Radiosensitizing Agent in Patients with Rectal Cancer; NCT00158886
Topotecan Post-Study Minimal Follow-up Report
- StudyEvent: ODM
Description
Month of Report
Alias
- UMLS CUI-1
- C1704685
- UMLS CUI-2
- C0439231
Description
Follow-Up Report, Month
Type de données
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Description
Follow-Up Report, Month
Type de données
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Description
Outcome
Alias
- UMLS CUI-1
- C1547647
Description
Patient Outcome, Cessation of life
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0011065
Description
Patient Outcome, Date last contact
Type de données
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0805839
Description
Patient Outcome, Lost to follow-up
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C1302313
Description
Patient Outcome, Disease Progression
Type de données
text
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0242656
Description
Patient Outcome, Disease Progression, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0242656
- UMLS CUI [1,3]
- C0011008
Description
Patient Outcome, Cancer treatment
Type de données
text
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0920425
Description
Patient Outcome, Cancer treatment, Start Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0920425
- UMLS CUI [1,3]
- C0808070
Description
Form D
Alias
- UMLS CUI-1
- C0011065
Description
Cause of Death
Type de données
text
Alias
- UMLS CUI [1]
- C0007465
Description
Cause of Death
Type de données
text
Alias
- UMLS CUI [1]
- C0007465
Description
Date of death
Type de données
date
Alias
- UMLS CUI [1]
- C1148348
Description
Cessation of life, Autopsy
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C0004398
Description
Cessation of life, Autopsy, Finding
Type de données
text
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C0004398
- UMLS CUI [1,3]
- C0243095
Description
Investigator's Signature
Alias
- UMLS CUI-1
- C2346576
Description
Investigator Signature
Type de données
text
Alias
- UMLS CUI [1]
- C2346576
Description
Investigator Signature, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Topotecan Post-Study Minimal Follow-up Report
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0011065 (UMLS CUI [1,2])
C0805839 (UMLS CUI [1,2])
C1302313 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0920425 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C0004398 (UMLS CUI [1,2])
C0004398 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])